[1] 邓艳华, 刘建民.甲状旁腺良恶性肿瘤的鉴别[J].诊断学理论与实践, 2010, 9(6):622.
[2] 王寅, 薛改琴, 王宇翔, 等.正常甲状旁腺超声特点及其临床意义[J].肿瘤研究与临床, 2019, 31(10):690. doi: 10.3760/cma.j.issn.1006-9801.2019.10.010
[3] 章建全, 仇明.正常人甲状旁腺超声影像特征的筛查及验证[J].第二军医大学学报, 2013, 34(5):349.
[4] 张俊花, 薛改琴.彩色多普勒超声对原发性甲状旁腺肿瘤的诊断价值[J].中国药物与临床, 2015, 15(4):507.
[5] 谭屾, 崔爱民, 柏楠, 等.甲状旁腺癌8例的诊治及围手术期PTH、Ca水平分析[J].山西医科大学学报, 2017, 48(10):1066.
[6] 周远.39例甲状旁腺腺瘤的临床特点及外科治疗分析[D].吉林: 吉林大学, 2018.
[7] 张小会, 胡成进, 王延群.甲状旁腺激素及其他生化指标在继发性甲状旁腺功能亢进手术中的应用[J].国际检验医学杂志, 2019, 40(17):2128. doi: 10.3969/j.issn.1673-4130.2019.17.019
[8] 童传明, 郑荆州, 吴高松.原发性甲状旁腺功能亢进症115例诊治分析[J].中华内分泌外科杂志, 2016, 10(1):45. doi: 10.3760/cma.j.issn.1674-6090.2016.01.012
[9] MOURE D, LARRANAGA E, DOMINGUEZ GL, et al.99mTcsestamibi as sole technique in selection of primary hyperparathyroidism patients for unilateral neck exploration[J].Surgery, 2008, 144(3):454. doi: 10.1016/j.surg.2008.05.014
[10] NIECIECKI M, CACKO M, KROLICKI L.The role of ultrasound and nuclear medicine methods in thepreoperative diagnostics of primary hyperparathyroidism[J].J Ultrason, 2015, 63(15):398.
[11] 张俊花.超声检查在甲状旁腺疾病诊疗中的临床应用[J].肿瘤影像学, 2019, 28(4):271.
[12] FANG C, KONSTANTATOU E, MULHOLLAND NJ, et al.A retrospective review of the role of B-mode and color doppler ultrasonography in the investigation of primary hyperparathyroidism:features that differentiate benign from malignant lesions[J].J Ultrason, 2018, 26(2):110.